MyAverix Finance
SHE · Healthcare
Henan Newland Pharmaceutical Co. Ltd. A (301277)
Drug Manufacturers - Specialty & Generic
Henan Newland Pharmaceutical Co. Ltd. A (301277) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $4.60B, P/E ratio is 37.87, net margin is 18.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301277
Henan Newland Pharmaceutical Co. Ltd. A (301277) — FAQ
What is Henan Newland Pharmaceutical Co. Ltd. A's market cap?
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a reported market cap of $4.60B (data as of 2026-03-29).
What is 301277's P/E ratio?
The price-to-earnings (P/E) ratio for Henan Newland Pharmaceutical Co. Ltd. A (301277) is 37.87 (data as of 2026-03-29).
Does Henan Newland Pharmaceutical Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Henan Newland Pharmaceutical Co. Ltd. A (301277). Check the MyAverix Finance app for the latest dividend data.
What sector is Henan Newland Pharmaceutical Co. Ltd. A in?
Henan Newland Pharmaceutical Co. Ltd. A (301277) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301277 listed on?
301277 is listed on SHE.
What is Henan Newland Pharmaceutical Co. Ltd. A's net margin?
Henan Newland Pharmaceutical Co. Ltd. A (301277) reports a net margin of 18.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.